Found 0 matching trials
Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients PHASE4 The current study is a prospective, randomized, open, multi-center investig...
Show More Location
Xixi Hospital of Hangzhou
Learn More & Join Trial
Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED) N/A Patients receiving a patient assistance program during therapy for Hepatiti...
Show More Location
Multiple Locations
Learn More & Join Trial
Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis PHASE2 Background:
Chronic hepatitis D is a serious liver disease caused by a vir...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection PHASE2 Interleukin 29 (IL-29) is a substance that is produced in the body to help ...
Show More Location
Multiple Locations
Learn More & Join Trial
Neutrino Regimen for Treatment-experienced HCV GT1 Patients PHASE4 This study will evaluate the efficacy and safety of NEUTRINO regimen in Chi...
Show More Location
Liver Fibrosis Diagnosis and Treatment Centre, 302 Hospital
Learn More & Join Trial
Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C PHASE3 This study is to evaluate the overall efficacy, and safety profile of the t...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Effects of Sho-saiko-to, a Herbal Formula, in Reducing Viral Load in Hepatitis C PHASE1 The purpose of this study is to (1) determine the effects of the herbal for...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C PHASE2 This phase 2b study will evaluate the efficacy and safety of 16 and 24 week...
Show More Learn More & Join Trial
REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection PHASE2 NAPs have been previously shown to clear serum hepatitis B virus surface an...
Show More Location
Infectious Clinical Hospital (n.a. Toma Ciorba) Department 5
Learn More & Join Trial
Effect of Boceprevir on HCV-specific T Cell Responses N/A Analysis of HCV-specific T cell responses in patients treated with boceprev...
Show More Location
Unit of Infectious Diseases and Hepatology
Learn More & Join Trial